Levetiracetam reduces tonic-clonic seizures by over 77% in clinical studies. Ethosuximide is highly effective for absence seizures, especially in children. Valproate remains the gold standard for ...

A new drug candidate has shown impressive results in a mid-stage clinical trial for drug-resistant epilepsy, raising hopes for patients who continue to suffer seizures despite being on multiple ...

A study found that most individuals diagnosed with focal epilepsy take over a year and more than one medication to be free of seizures. The study, led by researchers from the U.S. and Australia and ...

Researchers one step closer To quick stop seizures. February 15, 2012— -- The longer an epileptic seizure lasts, the more likely it is to turn deadly. Besides administering an oral or anal gel ...

Epilepsy is a disorder of the brain that affects the nervous system. Epilepsy causes abnormal electrical activity in the brain, which leads to seizures. There are many types of seizure medication, all ...

ATLANTA — Epilepsy experts are getting a better picture of the long-term safety and efficacy of azetukalner, a novel and potent Kv7 potassium channel opener, in patients with treatment-resistant focal ...

Please provide your email address to receive an email when new articles are posted on . Monthly seizure frequency percentage reduction was 68.73% for the entire study cohort. For those followed up in ...

Medication has long been the cornerstone of treatment for people with epilepsy, but it doesn't stop seizures for everyone and may come with significant side effects. New options in use or under ...

For the first time, clinicians have access to a clear, evidence-based roadmap for adjusting antiseizure medication doses ...